# MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29
Canonical URL: https://biopharmsignal.com/news/MDXG/mimedx-to-host-second-quarter-2026-operating-and-financial-results-conference-ca-b62fe7a7
Ticker: MDXG
Company: MiMedx
Source: MiMedx
Published: 2026-07-20 12:00 EST
Original Source URL: https://mimedx.gcs-web.com/news-releases/news-release-details/mimedx-host-second-quarter-2026-operating-and-financial-results
## Summary

The Investor Relations website contains information about MIMEDX Group, Inc.'s business for stockholders, potential investors, and financial analysts.

## Article Body
MARIETTA, Ga., July 20, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2026 after the market close on Wednesday, July 29, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here U.S. Investors: 877-407-6184 International Investors: 201-389-0877 Conference ID: 13761338

A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.

About MIMEDX MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com .

Contact: Matt Notarianni Investor Relations 470-304-7291 mnotarianni@mimedx.com
## Recent Company News
- 2026-07-20 12:00 EST — [MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29](https://biopharmsignal.com/news/MDXG/mimedx-to-host-second-quarter-2026-operating-and-financial-results-conference-ca-b62fe7a7) — Source: MiMedx
- 2026-05-21 12:45 EST — [MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference](https://biopharmsignal.com/news/MDXG/mimedx-to-participate-in-craig-hallum-23rd-annual-institutional-investor-conference) — Source: MiMedx
- 2026-05-08 12:00 EST — [MIMEDX Announces Launch of G4Derm® Plus](https://biopharmsignal.com/news/MDXG/mimedx-announces-launch-of-g4dermr-plus) — Source: MiMedx
- 2026-04-29 20:01 EST — [MIMEDX Announces First Quarter 2026 Operating & Financial Results](https://biopharmsignal.com/news/MDXG/mimedx-announces-first-quarter-2026-operating-and-financial-results) — Source: MiMedx
- 2026-04-22 12:00 EST — [MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29](https://biopharmsignal.com/news/MDXG/mimedx-to-host-first-quarter-2026-operating-and-financial-results-conference-call-on-april-29) — Source: MiMedx
## Related News
- 2026-07-22 21:05 EST — SUPN — [Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026](https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-announce-second-quarter-2026-financial-results-and-h-58b4f63d)
- 2026-07-22 20:15 EST — MOH — [Molina Healthcare Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/MOH/molina-healthcare-reports-second-quarter-2026-financial-results-343e2d32)
- 2026-07-22 20:15 EST — BFRG — [BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-the-btig-virtual-biotechnology-conference-5880a10e)
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
